| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $192.6M | -24.3% |
| R&D Expense | $76.8M | -10.4% |
| SG&A Expense | $112.9M | -17.3% |
| Operating Income | -$14.0M | -320.4% |
| Pre-tax Income | $6.3M | -43.9% |
| Income Tax | $3.8M | -23.8% |
| Net Income | $2.5M | -60.0% |
| EPS (Basic) | $0.04 | -63.6% |
| EPS (Diluted) | $0.04 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.8M | +0.6% |
| Accounts Receivable | $34.2M | +1.9% |
| Inventory | $1.4M | +13.7% |
| Current Assets | $432.9M | -16.6% |
| Total Assets | $648.4M | +2.2% |
| Current Liabilities | $87.7M | -4.1% |
| Total Liabilities | $103.5M | -3.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.8M | -60.0% |
| Capital Expenditures | $383K | -43.6% |
| Investing Cash Flow | -$12.1M | -124.1% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | $12.4M | -60.3% |
| -63.6% |
| Stockholders' Equity |
| $544.9M |
| +3.4% |